| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8819050 | Archivos de Bronconeumología | 2017 | 6 Pages |
Abstract
This non-systematic review discusses the results of the latest trials, the possibilities of incorporating these drugs in first-line regimens, the criteria for patient selection, adverse effects, and the prospects of combinations with conventional treatment modalities, such as CT, radiation therapy, and antiangiogenic agents.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Julio Sánchez de Cos EscuÃn,